Sandbox cvsd3: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) No edit summary |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 2: | Line 2: | ||
{{XXXXX}} | {{XXXXX}} | ||
{{CMG}}; {{AE}} {{AZ}} | {{CMG}}; {{AE}} {{AZ}} | ||
| Line 16: | Line 15: | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
[[Category:Antiarrhythmic agents]] | [[Category:Antiarrhythmic agents]] | ||
Latest revision as of 19:52, 11 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
References
Adapted from the FDA Package Insert.